BY Elizabeth Ollero
on Jul 01, 2015
Flibanserin! The female “viagra” that is nothing like viagra. Let’s discuss.
There are two problems. I’ll break it down for ya:
1. Hypoactive Sexual Desire Disorder (HSDD). This is a woman’s ongoing lack of interest in sex, to the point where it causes her personal distress or problems in her relationships. It affects one in ten women, so it’s not uncommon, but until now there has never been an FDA approved drug to treat it. Madness!
2. 26 v. 0. Read More
BY kelsey haight
on Mar 22, 2014
Okay, orgasms matter and are hopefully central to your well being and happiness. But if they aren’t, YOU ARE NOT ALONE. According to an ABC report, about 75 percent of all women never reach orgasm from intercourse alone – and that is without the extra help of sex toys, hands or tongue. And 10 to 15 percent never climax under any circumstances. Orgasms are complex and require a number of physical, emotional, hormonal and psychological elements to line up just right. Read More
BY Amy Bucknam
on Nov 05, 2012
For years, men have had that little blue pill called Viagra that helps men improve their sex lives. Well, fret no more, ladies, because a new drug is in the works to boost female sexual arousal.
Tefina is a testosterone gel that is undergoing clinical trials in Australia and Canada, according to i09. But the sexiest part about this new drug - it's a nasal spray! Yes, hot. This drug is absorbed into the body through the nose within a few minutes, and affects the woman's sex drive within a few hours, according to ONENews. Read More
BY Catie Colliton
on May 24, 2010
The FDA is deciding on whether or not to endorse the latest medication for lady problems: flibanserin. Dubbed the “pink Viagra,” this pill does what the little blue pill did for men in increasing their sex drive, supposedly.
The medication alters the chemicals in a woman’s brain into thinking more sexual thoughts, and apparently the German manufacturers are not sure how they came upon this potential gold mine of a pill (an estimated $2 billion market in the US). Originally, flibanserin was designed to treat depression but failed. Read More